Recently, it has been approved as a treatment option for chronic weight management in individuals with a body mass index (BMI) of 27 or higher
Table of Contents How do these two peptides actually work at the molecular level
To view a copy of this licence, visit About this article Cite this article Zhang, W., Li, M., Zan, Y
However, deviating from recommended doses can lead to adverse effects and accidental overdoses
According to Novo Nordisk, a 64-week clinical trial with over 300 participants found that those with obesity or overweight who took the oral Wegovy pill once a day lost an average of 16.6% of their body weight for people who completed the trial, a similar amount to those who took the injectable form of Wegovy, which launched in 2021, on a weekly basis